<DOC>
	<DOCNO>NCT00710632</DOCNO>
	<brief_summary>RATIONALE : Screening test may identify people cancer high risk lose weight help doctor plan good treatment . PURPOSE : This clinical trial study well new screen tool work predict weight loss patient cancer .</brief_summary>
	<brief_title>Screening Predict Weight Loss Patients With Cancer</brief_title>
	<detailed_description>OBJECTIVES : - To identify people cancer great risk future weight loss development simple practical screening tool . - To estimate reliability Appetite Symptom Questionnaire ( part 1 ) . - To develop screen tool base ability optimal combination item three measure ( ASQ , MUST , CRP ) predict clinically significant weight loss three month ( part 2 ) . - To estimate sensitivity specificity various cut-points develop screen tool predict clinically significant weight loss ( &gt; 10 % weight loss 5 % 10 % weight loss BMI &lt; 20 kg/m^2 ) three month ( part 2 ) . OUTLINE : This two-part study . - Part 1 : Patients ask complete Appetite Symptom Questionnaire ( ASQ ) two occasion , one week apart . - Part 2 : Patients screen baseline risk malnutrition use Malnutrition Universal Screening Tool . Blood sample also take time establish level C-reactive protein patient complete ASQ . Patients weigh use calibrated scale height measurement obtain . Patients ask unplanned weight loss previous 3-6 month . Patients weigh 3 month . Percentage weight loss calculate 3 month .</detailed_description>
	<mesh_term>Weight Loss</mesh_term>
	<mesh_term>Gastrointestinal Neoplasms</mesh_term>
	<mesh_term>Cachexia</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Meets 1 follow criterion , depend part study : Part 1 : Receiving radiotherapy cancer Nottingham City Hospital Likely clinically stable duration one week ( i.e. , high risk disease treatmentrelated appetite weight loss ) Stable weight appetite Part 2 : Outpatient Nottingham City Hospital confirm diagnosis primary lung gastrointestinal cancer Lost 10 % preillness stable body weight Lost 5 % preillness stable body weight body mass index ( BMI ) less 20 kg/m^2 BMI â‰¥ 18.5 kg/m^2 PATIENT CHARACTERISTICS : No condition impair ability swallow Not receive enteral tube feed parenteral nutrition ( part 2 ) Able weigh ( part 2 ) PRIOR CONCURRENT THERAPY : See Disease Characteristics No concurrent radiotherapy head , neck upper gastrointestinal tract area</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>cachexia</keyword>
	<keyword>lung cancer</keyword>
	<keyword>gastrointestinal cancer</keyword>
	<keyword>unspecified adult solid tumor , protocol specific</keyword>
	<keyword>hematopoietic/lymphoid cancer</keyword>
</DOC>